Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Noah C Federman"'
Autor:
Alexander Upfill‐Brown, Susan Bukata, Nicholas M Bernthal, Alan L Felsenfeld, Scott D Nelson, Arun Singh, Katherine Wesseling‐Perry, Fritz C Eilber, Noah C Federman
Publikováno v:
JBMR Plus, Vol 3, Iss 10, Pp n/a-n/a (2019)
ABSTRACT Denosumab has been used successfully to treat disease‐associated osteoclast overactivity, including giant cell tumor of bone. Given its mechanism of action, denosumab is a potent potential treatment of other osteoclast bone dysplasias incl
Externí odkaz:
https://doaj.org/article/634a7574fa5949fca05f3da9a39ae284
Autor:
Shefali Chauhan, Emily Lian, Iman Habib, Qianqian Liu, Nicole M. Anders, Megan M. Bugg, Noah C. Federman, Joel M. Reid, Clinton F. Stewart, Tristan Cates, Joel E. Michalek, Charles Keller
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Rhabdomyosarcoma (RMS) is the most common childhood soft tissue sarcoma. For the alveolar subtype (ARMS), the presence of the PAX3::FOXO1 fusion gene and/or metastases are strong predictors of poor outcome. Metastatic PAX3::FOXO1 + ARMS ofte
Externí odkaz:
https://doaj.org/article/f0d777b3277b40b58dcedcf300719a97
Autor:
Jacquelyn N. Crane, Danielle S. Graham, Christine E. Mona, Scott D. Nelson, Alireza Samiei, David W. Dawson, Sarah M. Dry, Marwan G. Masri, Joseph G. Crompton, Matthias R. Benz, Johannes Czernin, Fritz C. Eilber, Thomas G. Graeber, Jeremie Calais, Noah C. Federman
Publikováno v:
Sarcoma, Vol 2023 (2023)
Objectives. Fibroblast activation protein alpha (FAP) is highly expressed by cancer-associated fibroblasts in multiple epithelial cancers. The aim of this study was to characterize FAP expression in sarcomas to explore its potential utility as a diag
Externí odkaz:
https://doaj.org/article/a828662be6a041cf8c63abd09b536c1a
Autor:
Charles W. Bishop, Akhtar Ashfaq, Joel Z. Melnick, Enrique Vazquez-Escarpanter, Jonathan A. Fialkow, Stephen A. Strugnell, John Choe, Kamyar Kalantar-Zadeh, Noah C. Federman, David Ng, John S. Adams
Publikováno v:
Nutrition. 107:111899
ObjectivesThis double-blind randomized controlled trial investigated raising serum 25-hydroxyvitamin D (25D) with extended-release calcifediol (ERC) on time to symptom resolution in patients with mild to moderate COVID-19.MethodsCOVID-19 outpatients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::190bd7a81d82723ed1b2b56b64c01492
https://doi.org/10.1016/j.nut.2022.111899
https://doi.org/10.1016/j.nut.2022.111899
Autor:
Charles W. Bishop, Akhtar Ashfaq, Joel Z. Melnick, Enrique Vazquez-Escarpanter, Jonathan A. Fialkow, Stephen A. Strugnell, John Choe, Kamyar Kalantar-Zadeh, Noah C. Federman, David Ng, John S. Adams
ImportanceThe benefit of vitamin D treatment for coronavirus disease 2019 (COVID-19) remains unclear.ObjectiveTo investigate the effect of raising serum total 25-hydroxyvitamin D (25D) to 50-100 ng/mL with oral extended-release calcifediol (ERC) on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::612cd01d294d8b112ee155aad6eeb912
https://doi.org/10.1101/2022.01.31.22270036
https://doi.org/10.1101/2022.01.31.22270036
Autor:
Elizabeth Donovan, Sarah R Martin, Laura C Seidman, Lonnie K Zeltzer, Tara M Cousineau, Laura A Payne, Meredith Trant, Marjorie Weiman, Marla Knoll, Noah C Federman
BACKGROUND Approximately 70,000 adolescents and young adults (AYA) are diagnosed with cancer each year in the United States. Sarcomas carry a particularly high symptom burden and are some of the most common cancers among AYA. Recent work has document
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee624d022df75684dd11f0763fecef7f
https://doi.org/10.2196/preprints.10921
https://doi.org/10.2196/preprints.10921